We selected seven genes [4 unique genes (E2F6, TFDP1, SUV39H1, and HNRPD) for NSCLC and 3 genes (RBL1, IRF1, and HMGA1) for general events] for validation as diagnostic markers in lung cancer. This evidence concerns the gene RBL1 and lung carcinoma.